Platform Specialty Chemicals to Launch IPO

With three major acquisitions under its belt this year, Miami, Florida-based Platform Specialty Chemicals has launched a $350 million initial public offering to cover its past purchases and fund further growth.

The ipo, for which a share price has not yet been announced, will follow a $300 million offering in May of this year and a $651 million offering in October.

The Miami chemical firm's purchases during 2014 include three agrochemicals business, including Belgium's Agriphar for $300 million, Ireland-based Arysta Life Science for $3.5 billion and Chemtura AgroSolutions, a subsidiary of US chemical producer Chemtura for $1 billion.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.